Who we are
ABOUT MEDICINES FOR EUROPE
PURPOSE AND OBJECTIVES
OUR VALUES – OUR 5 PILLARS
STRUCTURE
MEMBERS
BECOME A MEMBER
CODE OF CONDUCT
DISCLOSURE
Vacancies
PRIORITIES
Key topics
ACCESS
INDUSTRIAL POLICY
REGULATORY AND LEGAL FRAMEWORK
FALSIFIED MEDICINES
SUSTAINABILITY
ANTIMICROBIAL RESISTANCE
MEDICINE SHORTAGES
Publications
EXTERNAL RESOURCES
FACTSHEETS
INFOGRAPHICS
PODCAST
POLICY
REPORTS
VIDEOS
Newsroom
IN THE NEWS
PRESS RELEASES
Contact us
Login
Generic medicines
Home
Medicines for Europe
Generic medicines Group
MISSION AND VISION
STRUCTURE
MEMBERS
BECOME A MEMBER
Did you know?
Definition
THERAPEUTIC AREAS
GLOSSARY
Q&A
What’s new
FACTSHEETS
POLICY
REPORTS
VIDEOS
INFOGRAPHICS
Our 5 pillars
Patients
QUALITY
VALUE
SUSTAINABILITY
PARTNERSHIP
Find out more
Related links
Contact us
Twitter
Biosimilar medicines
Home
Medicines for Europe
Biosimilar medicines Group
MISSION AND VISION
STRUCTURE
MEMBERS
BECOME A MEMBER
Did you know?
DEFINITION
THERAPEUTIC AREAS
GLOSSARY
Q&A
What’s new
FACTSHEETS
POLICY
REPORTS
VIDEOS
INFOGRAPHICS
External resources
Our 5 pillars
Patients
QUALITY
VALUE
SUSTAINABILITY
PARTNERSHIP
Find out more
Related links
Contact us
Twitter
Value added medicines
Home
Who we are
Value added medicines Group
MISSION AND VISION
STRUCTURE
MEMBERS
BECOME A MEMBER
Did you know?
Definition
THERAPEUTIC AREAS
Q&A
What’s new
FACTSHEETS
POLICY
REPORTS
VIDEOS
INFOGRAPHICS
Our 5 pillars
Patients
QUALITY
VALUE
SUSTAINABILITY
PARTNERSHIP
Find out more
Contact us
Events
Ensuring equitable and sustainable access to medicines through a secure and resilient supply
Permanent Representation of the Czech Republic to the EU
10 November 2022
OPEN AGENDA
REGISTER NOW
RESOURCES
The joint EFCG-Medicines for Europe paper on active pharmaceutical ingredients can be accessed at
https://www.medicinesforeurope.com/wp-content/uploads/2022/11/A-Strong-European-API-Industry-Can-Achieve-Strategic-Autonomy-of-the-EU-Health-System-1.pdf
For data on inequities in access to medicines in the region, Medicines for Europe’s report, entitled “Removing access barriers in Central and Eastern Europe: How can we ensure equitable access to medicines for all European patients?” is available at
https://www.medicinesforeurope.com/wp-content/uploads/2022/04/Removing-access-barriers-in-Central-and-Eastern-Europe-April-2022.pdf
A dedicated podcast on access issues in the CEE region is available at
https://www.medicinesforeurope.com/podcast/
Related Posts
Letta Report underlines need to improve equitable…
19 April 2024
Enrico Letta’s Report on the Future of the Single Market…
Prioritising access and EU solidarity should drive…
19 June 2024
Ministers of Health will meet in Brussels on Friday 21st…
‘Access Is A Right, Not A Privilege’ – Medicines For…
9 February 2026
The president of Medicines for Europe, Steffen Saltofte, says Medicines…
Position Paper - Revision of the Pharmaceutical legislation
8 January 2024
Medicines for Europe is committed to improving public health through…
Medicines For Europe
Who we are
Vacancies
PRIORITIES
Key topics – COVID-19
Publications
Newsroom
Contact us
SECTOR GROUPS
Generic medicines
WHO WE ARE
DID YOU KNOW?
WHAT’S NEW
OUR 5 PILLARS
FIND OUT MORE
Biosimilar medicines
WHO WE ARE
DID YOU KNOW?
WHAT’S NEW
OUR 5 PILLARS
FIND OUT MORE
Value added medicines
WHO WE ARE
DID YOU KNOW?
WHAT’S NEW
OUR 5 PILLARS
Events
Search
Share This
LinkedIn
Share on Mastodon
Enter your Mastodon instance URL (optional)
Share
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.
Ok